GlassScriptPhysician profile
William Keith Harris
NPI 1720015415
$2,690.09
in general payments reported to CMS, 2019-2025
32 companies · $389 in 2025
The $389 reported for 2025 was more than what a typical Obstetrics & Gynecology provider received nationally (typical 2025 total: $158).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $378 · 2020: $111 · 2022: $526 · 2023: $655 · 2024: $632 · 2025: $389.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,659 · Education: $16.35.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,659.32 |
| Education | $16.35 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbvie INC. | $666.56 | 2019-2023 | |
| Astellas Pharma US INC | $290.53 | 2023-2024 | Veozah |
| Mayne Pharma Commercial LLC | $257.47 | 2022-2025 | |
| Agile Therapeutics, INC. | $174.45 | 2022-2024 | Twirla |
| Millicent US INC | $161.98 | 2023-2025 | Femring, Intrarosa, Femlyv |
| Therapeuticsmd, INC. | $119.23 | 2019-2022 | |
| Sumitomo Pharma America, INC. | $105.04 | 2023-2025 | Myfembree |
| Exeltis, USA INC. | $101.63 | 2022-2024 | Tyblume |
| Myriad Women'S Health, INC. | $86.91 | 2023 | Myrisk |
| Bayer Healthcare Pharmaceuticals INC. | $81.14 | 2022-2025 | |
| Pfizer INC. | $66.93 | 2024-2025 | |
| Meditrina | $63.78 | 2022-2025 | |
| Minerva Surgical, INC | $48.34 | 2024 | |
| Intuitive Surgical, INC. | $39.74 | 2020-2023 | |
| Ascend Therapeutics US, LLC | $35.20 | 2020 |
Show all 32 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Amag Pharmaceuticals, INC. | $34.60 | 2019-2020 | |
| Sage Therapeutics, LLC | $33.35 | 2025 | Zurzuvae |
| Channel Medsystems, INC. | $32.07 | 2022 | |
| Kowa Pharmaceuticals America, INC. | $30.18 | 2023 | Seglentis |
| Hologic Sales and Service, LLC | $29.16 | 2024 | Fluent Fluid Management System, Novasure, Myosure Tissue Removal Device |
| Avion Pharmaceuticals | $27.03 | 2019-2020 | |
| Lilly USA, LLC | $26.84 | 2019-2024 | Zepbound, Jardiance |
| Dexcom, INC. | $23.49 | 2025 | Dexcom G6 Transmitter |
| Lupin INC. | $22.00 | 2019 | |
| Organon LLC | $21.57 | 2025 | Jada System |
| Exact Sciences Corporation | $19.60 | 2023 | Cologuard Collection Kit |
| Covidien LP | $19.40 | 2019 | |
| Supernus Pharmaceuticals, INC. | $17.40 | 2025 | Qelbree |
| Boston Scientific Corporation | $13.69 | 2019 | |
| Merck Sharp & Dohme LLC | $13.67 | 2019 | |
| Astrazeneca Pharmaceuticals LP | $13.60 | 2024 | Airsupra |
| Kci USA, INC. | $13.51 | 2023 | Abthera, V.A.C. Veraflo Cleanse Choice, 3m Avagard |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw William Harris listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.